A recent review in JAMA reveals that low-dose corticosteroids may reduce mortality in critically ill adults with severe pulmonary infections, including COVID-19, community-acquired bacterial pneumonia, and Pneumocystis pneumonia.
External experts have unanimously recommended the use of updated COVID-19 vaccines targeting the KP.2 variant, with manufacturers like Moderna and Novavax working on updating their vaccines for the 2024-25 immunization campaign.
Nearly three months into the bird flu outbreak, U.S. testing is alarmingly low, raising concerns about undetected spread and preparedness for a potential pandemic.
KFF Health News
Daily News
Stay up to date with the latest clinical headlines.
The Congressional Budget Office projects a rise in the uninsured rate to 8.9% by 2034, driven by immigration and policy changes affecting young adults, despite a record low of 7.2% in 2023.
A study in JAMA Network Open shows a rise in influenza vaccination mandates for U.S. health care personnel, with VA hospitals increasing from 4% in 2017 to 96% in 2021.
Study finds severe neurological manifestations in children hospitalized with COVID-19 or MIS-C linked to increased risk of new neurocognitive and functional morbidities.